Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the thyroid gland (HP:0000820)help
Parent Node:
expand
Abnormality of thyroid physiology (HP:0002926)help
..Starting node
..expand
Hyperthyroidism (HP:0000836)help
Term ID: 836
Name: Hyperthyroidism
Synonym: Overactive thyroid
Definition: An abnormality of thyroid physiology characterized by excessive secretion of the thyroid hormones thyroxine (i.e., T4) and/or 3,3',5-triiodo-L-thyronine zwitterion (i.e., triiodothyronine or T3).
Comments:
Reference: HP:0000836
Genes and Diseases:
 
       Child Nodes:
........expandThyroid crisis (HP:0011782) help
........expandThyrotoxicosis from ectopic thyroid tissue (HP:0011783) help
........expandThyrotoxicosis with diffuse goiter (HP:0011784) help
................... HP:0100647 Graves disease
........expandThyrotoxicosis with toxic multinodular goitre (HP:0011785) help
........expandThyrotoxicosis with toxic single thyroid nodule (HP:0011786) help

 Sister Nodes: 
..expandAbnormal circulating thyroid hormone concentration (HP:0031508) help
..expandAbnormal radioactive iodine uptake test result (HP:0031221) help
..expandEuthyroid hyperthyroxinemia (HP:0008247) help
..expandHypothyroidism (HP:0000821) help
..expandImpaired sensitivity to thyroid hormone (HP:0002930) help
..expandImpaired sensitivity to thyroid stimulating hormone (HP:0011789) help
..expandPositive perchlorate discharge test (HP:0025482) help
..expandThyroid defect in oxidation and organification of iodide (HP:0008263) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000836HP:0000836Hyperthyroidism0AKT1 CL E G H207391OMIM:615109Cowden syndrome 6.54
HP:0000836HP:0000836Hyperthyroidism0ARVCF CL E G H421728ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional1
HP:0000836HP:0000836Hyperthyroidism0BTNL2 CL E G H562441142ORPHA:797SarcoidosisHP:0040284 - Very rare1
HP:0000836HP:0000836Hyperthyroidism0CACNA1S CL E G H7791397ORPHA:79102Thyrotoxic periodic paralysisHP:0040280 - Obligate247
HP:0000836HP:0000836Hyperthyroidism0CACNA1S CL E G H7791397OMIM:188580Thyrotoxic periodic paralysis, susceptibility to, 1.247
HP:0000836HP:0000836Hyperthyroidism0CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040281 - Very frequent636
HP:0000836HP:0000836Hyperthyroidism0CLCNKB CL E G H11882027ORPHA:358Gitelman syndrome27
HP:0000836HP:0000836Hyperthyroidism0COMT CL E G H13122228ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional6
HP:0000836HP:0000836Hyperthyroidism0FMR1 CL E G H23323775ORPHA:449291Symptomatic form of fragile X syndrome in female carriersHP:0040283 - Occasional30
HP:0000836HP:0000836Hyperthyroidism0FOXP3 CL E G H509436106ORPHA:37042Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndromeHP:0040284 - Very rare32
HP:0000836HP:0000836Hyperthyroidism0GABRA3 CL E G H25564077ORPHA:79102Thyrotoxic periodic paralysisHP:0040280 - Obligate
HP:0000836HP:0000836Hyperthyroidism0GNAS CL E G H27784392ORPHA:562McCune-Albright syndromeHP:0040282 - Frequent101
HP:0000836HP:0000836Hyperthyroidism0GNAS CL E G H27784392OMIM:174800McCune-Albright syndrome, somatic, mosaic.101
HP:0000836HP:0000836Hyperthyroidism0GP1BB CL E G H28124440ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional8
HP:0000836HP:0000836Hyperthyroidism0HIRA CL E G H72904916ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional3
HP:0000836HP:0000836Hyperthyroidism0HLA-DRB1 CL E G H31234948ORPHA:797SarcoidosisHP:0040284 - Very rare2
HP:0000836HP:0000836Hyperthyroidism0JMJD1C CL E G H22103712313ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional2
HP:0000836HP:0000836Hyperthyroidism0KCNJ18 CL E G H10013444439080ORPHA:79102Thyrotoxic periodic paralysisHP:0040280 - Obligate10
HP:0000836HP:0000836Hyperthyroidism0KCNJ18 CL E G H10013444439080OMIM:613239Thyrotoxic periodic paralysis, susceptibility to, 2.10
HP:0000836HP:0000836Hyperthyroidism0KCNJ2 CL E G H37596263OMIM:170390Andersen cardiodysrhythmic periodic paralysis193
HP:0000836HP:0000836Hyperthyroidism0MSTO1 CL E G H5515429678ORPHA:502423Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndromeHP:0040282 - Frequent
HP:0000836HP:0000836Hyperthyroidism0MSTO1 CL E G H5515429678OMIM:617675Myopathy, mitochondrial, and ataxia.
HP:0000836HP:0000836Hyperthyroidism0PIK3CA CL E G H52908975OMIM:615108Cowden syndrome 5.162
HP:0000836HP:0000836Hyperthyroidism0POLG CL E G H54289179ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040284 - Very rare464
HP:0000836HP:0000836Hyperthyroidism0POLG2 CL E G H112329180ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040284 - Very rare45
HP:0000836HP:0000836Hyperthyroidism0POLR3A CL E G H1112830074ORPHA:3455Wiedemann-Rautenstrauch syndromeHP:0040284 - Very rare138
HP:0000836HP:0000836Hyperthyroidism0PTEN CL E G H57289588OMIM:158350Cowden syndrome 1.948
HP:0000836HP:0000836Hyperthyroidism0RREB1 CL E G H623910449ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional
HP:0000836HP:0000836Hyperthyroidism0RRM2B CL E G H5048417296ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040284 - Very rare125
HP:0000836HP:0000836Hyperthyroidism0SEC24C CL E G H963210705ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional
HP:0000836HP:0000836Hyperthyroidism0SLC12A3 CL E G H655910912ORPHA:358Gitelman syndrome145
HP:0000836HP:0000836Hyperthyroidism0SLC25A4 CL E G H29110990ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040284 - Very rare68
HP:0000836HP:0000836Hyperthyroidism0SUGCT CL E G H7978316001OMIM:231690Glutaric aciduria IIIHP:0040283 - Occasional8
HP:0000836HP:0000836Hyperthyroidism0TBCK CL E G H9362728261ORPHA:488632TBCK-related intellectual disability syndromeHP:0040284 - Very rare13
HP:0000836HP:0000836Hyperthyroidism0TBX1 CL E G H689911592ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional32
HP:0000836HP:0000836Hyperthyroidism0THRB CL E G H706811799OMIM:145650Thyroid hormone resistance, selective pituitary.161
HP:0000836HP:0000836Hyperthyroidism0TSHR CL E G H725312373ORPHA:99819Familial gestational hyperthyroidismHP:0040280 - Obligate97
HP:0000836HP:0000836Hyperthyroidism0TSHR CL E G H725312373ORPHA:424Familial hyperthyroidism due to mutations in TSH receptorHP:0040280 - Obligate97
HP:0000836HP:0000836Hyperthyroidism0TSHR CL E G H725312373OMIM:603373HYPERTHYROIDISM, FAMILIAL GESTATIONAL97
HP:0000836HP:0000836Hyperthyroidism0TSHR CL E G H725312373OMIM:609152Hyperthyroidism, nonautoimmune.97
HP:0000836HP:0000836Hyperthyroidism0TWNK CL E G H566521160ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040284 - Very rare113
HP:0000836HP:0000836Hyperthyroidism0UFD1 CL E G H735312520ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional
HP:0000836HP:0011783Thyrotoxicosis from ectopic thyroid tissue1 CL E G H
HP:0000836HP:0011785Thyrotoxicosis with toxic multinodular goiter1CACNA1S CL E G H7791397ORPHA:79102Thyrotoxic periodic paralysisHP:0040281 - Very frequent247
HP:0000836HP:0011786Thyrotoxicosis with toxic single thyroid nodule1CACNA1S CL E G H7791397ORPHA:79102Thyrotoxic periodic paralysisHP:0040281 - Very frequent247
HP:0000836HP:0011784Thyrotoxicosis with diffuse goiter1CACNA1S CL E G H7791397ORPHA:79102Thyrotoxic periodic paralysisHP:0040281 - Very frequent247
HP:0000836HP:0011782Thyroid crisis1CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040282 - Frequent636
HP:0000836HP:0011784Thyrotoxicosis with diffuse goiter1CLCNKB CL E G H11882027ORPHA:358Gitelman syndrome27
HP:0000836HP:0011784Thyrotoxicosis with diffuse goiter1GABRA3 CL E G H25564077ORPHA:79102Thyrotoxic periodic paralysisHP:0040281 - Very frequent
HP:0000836HP:0011785Thyrotoxicosis with toxic multinodular goiter1GABRA3 CL E G H25564077ORPHA:79102Thyrotoxic periodic paralysisHP:0040281 - Very frequent
HP:0000836HP:0011786Thyrotoxicosis with toxic single thyroid nodule1GABRA3 CL E G H25564077ORPHA:79102Thyrotoxic periodic paralysisHP:0040281 - Very frequent
HP:0000836HP:0011785Thyrotoxicosis with toxic multinodular goiter1KCNJ18 CL E G H10013444439080ORPHA:79102Thyrotoxic periodic paralysisHP:0040281 - Very frequent10
HP:0000836HP:0011786Thyrotoxicosis with toxic single thyroid nodule1KCNJ18 CL E G H10013444439080ORPHA:79102Thyrotoxic periodic paralysisHP:0040281 - Very frequent10
HP:0000836HP:0011784Thyrotoxicosis with diffuse goiter1KCNJ18 CL E G H10013444439080ORPHA:79102Thyrotoxic periodic paralysisHP:0040281 - Very frequent10
HP:0000836HP:0011784Thyrotoxicosis with diffuse goiter1SLC12A3 CL E G H655910912ORPHA:358Gitelman syndrome145
HP:0000836HP:0011784Thyrotoxicosis with diffuse goiter1TSHR CL E G H725312373ORPHA:99819Familial gestational hyperthyroidismHP:0040281 - Very frequent97
HP:0000836HP:0011784Thyrotoxicosis with diffuse goiter1TSHR CL E G H725312373ORPHA:424Familial hyperthyroidism due to mutations in TSH receptorHP:0040281 - Very frequent97
HP:0000836HP:0100647Graves disease2CACNA1S CL E G H7791397ORPHA:79102Thyrotoxic periodic paralysisHP:0040281 - Very frequent247
HP:0000836HP:0100647Graves disease2CLCNKB CL E G H11882027ORPHA:358Gitelman syndromeHP:0040284 - Very rare27
HP:0000836HP:0100647Graves disease2GABRA3 CL E G H25564077ORPHA:79102Thyrotoxic periodic paralysisHP:0040281 - Very frequent
HP:0000836HP:0100647Graves disease2KCNJ18 CL E G H10013444439080ORPHA:79102Thyrotoxic periodic paralysisHP:0040281 - Very frequent10
HP:0000836HP:0100647Graves disease2SLC12A3 CL E G H655910912ORPHA:358Gitelman syndromeHP:0040284 - Very rare145


Genes (35) :AKT1 ARVCF BTNL2 CACNA1S CDH23 CLCNKB COMT FMR1 FOXP3 GABRA3 GNAS GP1BB HIRA HLA-DRB1 JMJD1C KCNJ18 KCNJ2 MSTO1 PIK3CA POLG POLG2 POLR3A PTEN RREB1 RRM2B SEC24C SLC12A3 SLC25A4 SUGCT TBCK TBX1 THRB TSHR TWNK UFD1

Diseases (26) :OMIM:615109 ORPHA:567 ORPHA:797 ORPHA:79102 OMIM:188580 ORPHA:91347 ORPHA:358 ORPHA:449291 ORPHA:37042 ORPHA:562 OMIM:174800 OMIM:613239 OMIM:170390 ORPHA:502423 OMIM:617675 OMIM:615108 ORPHA:254892 ORPHA:3455 OMIM:158350 OMIM:231690 ORPHA:488632 OMIM:145650 ORPHA:99819 ORPHA:424 OMIM:603373 OMIM:609152
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.